Americans may soon have access to a new sunscreen ingredient already used around the world.
The U.S. Food and Drug Administration announced Thursday that it is reviewing a proposal to allow bemotrizinol in sunscreens sold in the United States.
The ingredient is already approved and widely used in Europe, Australia and parts of Asia.
Bemotrizinol offers broad protection against both UVA and UVB rays, which are known to damage skin and raise cancer risk. The ingredient "has low levels of absorption through the skin into the body, and rarely causes skin irritation," an FDA news release said.
Related
